Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
139.70
Change Change %
-2.60 -1.83%

Updated:20 Feb, 2020, 15:55 PM IST

BSE
139.60
Change Change %
-3.05 -2.14%

Updated:20 Feb, 2020, 16:01 PM IST

Bliss GVS Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Gross Sales 298.29 350.27 -14.84%
Less :Inter divisional transfers 0.00 0.00 0.00%
Less: Sales Returns 0.00 0.00 0.00%
Less: Excise 0.40 2.26 -82.21%
Net Sales 297.89 348.02 -14.40%
EXPENDITURE:
Increase/Decrease in Stock -4.09 -6.93 40.96%
Raw Materials Consumed 149.90 174.14 -13.92%
Power & Fuel Cost 2.59 2.73 -5.18%
Employee Cost 26.29 25.03 5.03%
Other Manufacturing Expenses 3.64 3.31 9.78%
General and Administration Expenses 11.75 11.73 0.16%
Selling and Distribution Expenses 14.68 26.29 -44.17%
Miscellaneous Expenses 4.68 11.18 -58.17%
Expenses Capitalised 0.00 0.00 0.00%
Total Expenditure 209.43 247.49 -15.38%
PBIDT (Excl OI) 88.47 100.53 -12.00%
Other Income 11.00 9.08 21.12%
Operating Profit 99.46 109.61 -9.26%
Interest 6.95 9.07 -23.39%
PBDT 92.51 100.53 -7.98%
Depreciation 5.67 5.62 0.84%
Profit Before Taxation & Exceptional Items 86.84 94.91 -8.50%
Exceptional Income / Expenses 0.00 0.00 0.00%
Profit Before Tax 86.84 94.91 -8.50%
Provision for Tax 29.82 35.77 -16.63%
PAT 57.01 59.13 -3.58%
Extraordinary Items 0.00 0.00 0.00%
Adj to Profit After Tax 0.00 0.00 0.00%
Profit Balance B/F 422.21 375.25 12.51%
Appropriations 479.22 434.39 10.32%
Equity Dividend (%) 100.00 60.00 66.67%
Earnings Per Share (in ₹) 5.53 5.73 -3.58%
Book Value (in ₹) 52.49 47.66 10.13%
Top